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Mammalian cells in vivo must cope with the effects of reactive oxygen inter-
mediates generated by aerobic metabolism (1), by the catabolism of drugs and
other xenobiotics (2), by x-rays (3), and by the respiratory burst of phagocytic
cells (4) . Similarly, cells in vitro encounter reactive products generated in the
culture medium from the autooxidation of ascorbate (5) and sulfhydryls, notably
cysteine (6-9), and photooxidation of medium components such as riboflavin,
tyrosine, and tryptophan (10-12). Cells are usually cultured in 95% air, which
provides an oxygen tension far higher than that in mostbody fluids, exacerbating
oxidative stresses . Toxic reaction products generated include singlet oxygen,
superoxide anion, hydroxyl radical, and hydrogen peroxide (H202) . Of these,
only H202 has a long half-life and accumulates in the medium . There are major
gaps in our understandingof thebiochemistry ofoxidativeinjuryand antioxidant
defense . For example, we cannot yet fully explain the striking variation in
sensitivity of different cell types to lysis by H202 (13, 14) . Differences in the
function of catalase and of the glutathione (GSH)' redox cycle account for only
a portion of this variation (13-14) .
We are currently testing the hypothesis that a-ketoacids may be important
targets for injury of cells by H202 . It has been known since 1904 that H202
causes a rapid, nonenzymatic, and stoichiometric decarboxylation of pyruvate
(15, 15a) . Decomposition of pyruvate, oxaloacetate, and a-ketoglutarate could
cripple cellular synthesis of ATP from both glucose and glutamine (16) . A
precipitous decline in ATP appears to be a critical early step in cytolysis induced
by H202 (17) . While testing these ideas, we questioned why many cell culture
media formulations include pyruvate in addition to glucose . The practice stems
This work was supported by grants P01-30198, CA-43610, and GM-32725 from the National
Institutes of Health (Bethesda, MD)and grant PDT269 from the American Cancer Society . J . de la
Harpe is a recipient of a Cancer Research Institute/Antony J . Chandris Fellowship . J . O'Donnell-
Tormey is a recipient of an award from the Ruth Estrin Goldberg Memorial for Cancer Research .
Address correspondence to C. Nathan, Box 57, Cornell University Medical College, 1300 York Ave.,
NewYork, NY 10021 .
'Abbreviations used in this paper:
￿
aMEM, alpha-modified minimum Eagle's medium ; BSTFA,
N,O-bis-(trimethylsilyl)trifluoroacetamide ; DPBS, Dulbecco's PBS ; GC-MS, gaschromatography-mass
spectral analysis ; GSH, glutathione ; HS, horse serum ; LDH, lactic dehydrogenase ; M-5HS, aMEM
and HS ; MOX, hydroxylamine in pyridine ; MSD, mass-selective detector .
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from empiric observations a quarter century ago that pyruvate promotes the
survival of cells at low plating densities (18-21) . Contemporary studies demon-
strate that pyruvate can substitute for conditioned medium (22) or serum (23-
25) in supporting the growth of certain cells . The growth-promoting effect of
conditionedmedium hasbeen attributed to release ofendogenous pyruvate from
one cell type, astroglia (26) . Higuchi (27) observed that pyruvate countered the
toxic effect ofexogenous cysteine and that catalase could substitute for pyruvate .
However, despite these observations, no explanations have emerged either for
the similarity of the cytoprotective effect of most conditioned media and pyru-
vate, or for the mechanism of cell protection by pyruvate .
In the work reported below we found that H202 decarboxylated a-ketoacids
in a physiologic cell culture medium and that the reaction was rapid enough for
exogenous pyruvate to protect cells from lysis by H202 . All five types of mouse
and human cells tested released pyruvate until the extracellular concentration
approximated that observed in plasma and serum . Among the eight Embden-
Meyerhof and Krebs cycle intermediates measured in P815 cells, export was
limited to pyruvate and lactate . Exogenous catalase enhanced the rate of accu-
mulation of extracellular pyruvate . These results suggest that pyruvate is specif-
ically secreted, and functions extracellularly as an antioxidant .
Materials and Methods
Materials. a-modified minimum Eagle's medium (aMEM), RPMI, sodium pyruvate
(for tissue culture), and glutamine were from KC Biological, Inc ., Lenexa, KS . Both media
were supplemented with 0 .1 mM nonessential amino acids (Gibco Laboratories, Grand
Island, NY), 100 U/ml penicillin, and 100 ug/ml streptomycin ; RPMI was further
supplemented with 1 mM glutamine . The following were obtained from the indicated
sources : horse serum (HS) (HyClone Laboratories, Logan, UT) ; Dulbecco's PBS without
calcium and magnesium (DPBS ; Gibco Laboratories) ; Na t"CrO4 (620 mCi/mg Cr ; New
England Nuclear, Boston, MA) ; H202 (30% superoxol ; Fisher Chemical Co ., Fairlawn,
NJ) . The following were from Sigma Chemical Co ., St . Louis, MO : catalase (C 40) from
bovine liver, 11,000 Sigma U/mg protein; lactic dehydrogenase (LDH) type XI (L 1245)
from rabbit muscle, 75 U/mg protein ; NADH grade III (N 8129) disodium salt from
yeast ; pyruvate (for biochemical studies), lactate, fumarate, citrate, succinate, a-ketoglu-
tarate, malate, and oxaloacetate . For GC-MS experiments, oxaloacetic acid was 90-95%
pure ; all other acids were >98% pure . Octadecane, hydroxylamine hydrochloride, and
anhydrous pyridine (stored over calcium hydride) were from Aldrich Chemical Co .,
Milwaukee, WI . 2% hydroxylamine in pyridine (MOX) was freshly prepared before use .
N,0-bis-(trimethylsilyl)trifluoroacetamide (BSTFA) was from Pierce Chemical Co ., Rock-
ford, IL .
Cell Cultures. Mouse cell lines used were : P815 mastocytoma (nonadherent), P388
lymphoma (nonadherent), and L929, a connective tissue line (adherent) . Human cell lines
used were : CCD-21 SK, diploid skin fibroblasts (adherent), and SK-BR-2-III (nonadherent)
and CAMA-1 (adherent) breast adenocarcinomas . Cells were cultured in a hu-
midified atmosphere of 95% air, 5% C02 . Adherent cells were grown to confluence in
60-mm polystyrene tissue culture plates . Cell counts were obtained by individually tryp-
sinizing two plates and counting the cells in a hemocytometer . The mean of these counts
was taken to be representative for the remaining plates . At the start of the experiment
the medium was aspirated from the cells and they were washed three times with 3 ml
RPMI at 37°C and then brought to the desired cell density (usually 2.5 x 106/ml) by
adding the appropriate volume of this medium . The time of this final addition was taken
as time 0 for the experiment . Nonadherent cells were washed three times in 20 ml RPMI
at 37'C by centrifugation at 550 g for 7 min and then they were suspended at the desired502
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density (usually 2.5 X 106/ml) in RPMI . The time of this final resuspension was taken as
time 0 for the experiment . Nonadherent cells were cultured in 13-ml polystyrene culture
tubes (No . 2057 ; Falcon Labware, Oxnard, CA) secured at about 30° from the vertical
on a platform rotating at 100 rpm .
FluorimetricAssayforPyruvate.
￿
To measure pyruvate in the medium, an aliquot (usually
200 A,1) was withdrawn from the culture and centrifuged at 10,000 g for 10 s in a
microcentrifuge (5414 ; Eppendorf; Brinkmann Instruments Inc ., Westbury, NY) . For
adherent cells, a separate 60-mm plate was used for each measurement . From the
centrifuged supernatant, 100 y1 was transferred to a 5-ml glass tube and assayed imme-
diately, or stoppered and frozen at -80 °C for assay within 3 d . For the fluorometric
assay, 100 Al of 0.5 M ice-cold perchloric acid was added to this 100-Al sample . After 5
min on ice the perchloric acid was neutralized with 40 ,ul 2.5 M KHCO3 . This solution
was degassed under vacuum for 15 min on ice .
To measure intracellular pyruvate all medium was aspirated from adherent or pelleted
nonadherent cells . The cells were then incubated in 500 Al of 0.25M ice-cold perchloric
acid for 5 min, transferred (adherent cells were scraped with a rubber policeman) to a
1 .5-ml conical tube and centrifuged at 10,000 g for 10 s . An aliquot of the supernatant
was neutralized with KHCO 3 and degassed as described above .
The fluorimetric assay was a modification of the method of Lowry and Passonneau
(28) . Pyruvate was converted to lactate by LDH in the presence of NADH. The loss of
fluorescence (excitation 340 nm, emission 460 nm) as NADH was converted to NAD was
followed using a SPEX F112A photon-counting spectrofluorometer fitted with a cooled
photomultiplier (Spex Industries, Inc ., Edison, NJ). The assay system consisted of 0.4 ml
0.125 M sodium phosphate, pH 7.4, containing 2 .5 Amol NADH . To this we added 100
A1 of the sample to be assayed and we established the baseline fluorescence . The reaction
was started by adding 10 Al (400 Ag/ml) LDH and fluorescence followed until no further
change was observed . Pyruvate standards were carried through the same extraction
procedure (perchloric acid, KHCO 3 , degassing) and measured in the same manner to
provide a standard curve . It was necessary to screen reagent stocks and to use acid-washed
glassware to minimize fluorescent contamination .
The modifications implemented in the fluorescent pyruvate assay (28) resulted in linear
and reproducible standard curves (3% SEamong 19 standard curves) and dose-responsive
measurements of released and cell-associated pyruvate . Addition of exogenous pyruvate
to perchloric acid-treated cells resulted in a 97 ± 5% recovery (mean ± SE, n= 13) . The
limit of sensitivity of the modified assay was 0.084 nmol/100 Al sample, reflecting an
original pyruvate concentration in a nonextracted sample of 2 .0 AM . This limit is based
on the mean value for mock samples (pyruvate-free samples brought through the extrac-
tion procedure) + 1 SD (n = 19) . The modified fluorescent assay agrees with GC-MS
measurements of the same samples (r = 0.98) . Pyruvate in RPMI 1640 was stable at 37'C
or -70°C for the periods of accumulation and storage used in this study .
Gas Chromatography-Mass Spectral Analysis (GC-MS).
￿
A stock solution of acids was
prepared in water and neutralized withNaOH . Aliquots were diluted into vials and frozen
in dry ice-acetone . Aliquots (0.5 ml) of culture medium were prepared in a similar
manner . MOX (150 pl) was added to the vials after lyophilization for 1 h . After incubation
at 4°C overnight, 250 ul BSTFA was added along with 2 A1 of the internal standard
solution in pyridine . The derivative mixture was allowed to stand another 30 min before
a 2-Al sample was injected into the GC-MS system . Derivatives were prepared from
lyophilized medium or cell residue in a similar manner, except that the vials of the latter
were centrifuged briefly before removal ofa sample for injection .
GC-MS analyses of derivatives were performed using a HP5890A gas chromatograph
and HP5970B mass-selective detector (MSD) (Hewlett-Packard Co ., Palo Alto, CA) . The
HP59970A workstation is controlled by a series 200 computer with software for acquisi-
tion and analysis of GC-MS data . MSD source temperature was 200'C and electron
ionization energy was 70 eV . The 0.2-mm inner diam glass capillary column, either 12.5
or 15 m in length, was coated with a 0 .33 Am crosslinked dimethyl silicone film . The
column oven was maintained at 70°C for 3 .5 min after injection, increased at 5°C/minO'DONNELL-TORMEY ET AL .
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FIGURE 1 .
￿
The reaction ofH202 and pyruvate in RPMI 1640 medium . Pyruvate (5 Wmol)
and H 202 (5 pmol) in 1 ml RPMI 1640 were incubated at 37°C and the reaction was stopped
at indicated times by addition of 1,000 Sigma units of catalase . Residual pyruvate was
determined fluorometrically . Means t SE, n = 6 .
to 190 °C and then rapidly increased to 240-260°C to remove later-eluting components .
The helium flow rate through the column was 1 cc/min and total carrier gas flow rate
was 20 cc/min . Samples were injected using the splitless mode with a 2-min purge
activation time and an injection port temperature of 250 °C .
The acid derivatives and hydrocarbon internal standards were identified by comparison
of their retention times and mass spectra with those of authentic compounds (29, 30), and
those of the hydrocarbons showed characteristic fragmentation patterns . All spectra also
contained the predicted parent ion, and matched reference spectra in the National Bureau
of Standards mass spectral data base .
Cytolysis Assay.
￿
Susceptibility of cells to lysis by H202 was determined by a "Cr release
assay, as previously described (31) .
Cell Water Space .
￿
Cell water space was estimated by the method of Rottenberg (32)
using 'H20 and ['"C]sorbitol and related to cell protein in each assay .
Protein .
￿
We measured protein by the method of Lowry et al . (33) with BSA as the
standard .
H202 Measurement .
￿
Concentrations ofH202 were measured using an oxygen electrode
(model 53 Oxygen Monitor ; Yellow Springs InstrumentCo ., Yellow Springs,OH) as twice
the 02 generated by catalase (14) or by the scopoletin assay (34) .
Results
Reaction ofH202 with Pyruvate and Other a-Ketoacids .
￿
Using a complex cell
culture medium, we confirmed the original reports (15, 15a) that pyruvate in
the millimolar range reacts nonenzymatically with H202 in a 1 :1 stoichiometry
(data not shown) . The t,/ , of the reaction was less than 30 s when both reactants
were initially present at 5 mM (Fig . 1) .
To examine the specificity of this reaction for pyruvate, a mixture of 10 mM
each of pyruvate, oxaloacetate, fumarate, malate, lactate, and citrate was exposed
to 45 mM H202 . Fig. 2 shows the GGMS chromatogram of the organic acids
before and 10 min after exposure to H202 . The three a-ketoacids were totally
degraded. In contrast, the acids lactate and malate were quantitatively recovered
(100% and 101%, respectively), and the recovery of citrate was 92% . Some loss
of fumarate (42%) may be attributable to the double bond on the a-carbon . The
postreaction mixture showed the appearance of two new acids, malonate and
succinate, the decarboxylation products of oxaloacetate and a-ketoglutarate,
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Specificity of reaction with H202 for a-ketoacids . A mixture of organic acids
(pyruvate [1], lactate [2], fumarate [5], oxaloacetate [6], malate [7], a-ketoglutarate [8], and
citrate (9]), each at 10 mM, was exposed to 45 mM of H202 for 10 min. Samples of the
mixture before (A) and after (B) exposure to H202 were derivitized and analyzed by GC-MS .
Succinate (4) and malonate (3) are the decarboxylation products of oxaloacetate and a-
ketoglutarate, respectively . Acetate, the decarboxylation product of pyruvate, is too volatile
to be carried through the derivitization . Ordinate, abundance ; abscissa, retention time (min) .
respectively . Acetate, the decarboxylation product of pyruvate, is too volatile to
carry through the derivitization procedures, and was not detected .
Exogenous a-Ketoacids Protect Cells from Cytolysis by Exogenous H 202 .
￿
When
"Cr-labeled, P388 mouse lymphoma cells were exposed to H202, the addition
of pyruvate to the culture medium protected the cells against cytolysis in a dose-
dependent manner . Fig . 3 a shows the H202-induced cytolysis curves for P388N 0
U
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U
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Pyruvate (mM)
FIGURE 3.
￿
Effect of pyruvate on sensitivity of P388 cells to H202. 2 X 105 "Cr-labeled
cells/ml in M-5HS were incubated in the presence or absence of H202 (10-5 to 3 X 10-2 M)
and various concentrations of pyruvate for 3 h in 5% C02/95% air. (a) Specific "Cr release
wasplotted vs. H202 concentration. Added pyruvate (mM): 0 (O), 0.1 (p), 0.3 (p), 1.0 (p), 3.0
(0), 10 (0). (b)LD5o for H202 concentration wasplotted vs. thepyruvate concentration added.
Means of triplicates.
Effect ofa- and a-Ketoacids on Sensitivity ofP815 to H202
2 X 105 "Cr-labeled cells/ml in M-5HS were incubated with 10 mM of
the indicated agents in the presence of various concentrations of reagent
H202 for 3.5 h at 37°C in 5% C02, as shown in Fig. 3. Specific 'Cr
releasewasmeasured (31) and LD5o levels were calculated by interpolation.
The fold shift to right in the H202 dose-response curveis the ratio of the
LD5o in the presence oftheindicatedagent divided by that in theabsence.
in the presence of 0-10 mM pyruvate. The H202 concentration resulting in 50%
specific release of 51 Cr (LD5o) was a linear function of the concentration of
pyruvate added (r = 0.999) (Fig. 3b). The inability of pyruvate to provide
complete protection against the cytolytic effect of equimolar H202 presumably
reflects the fact that H202 reacts simultaneously with both extracellular pyruvate
and critical cellular components. We have previously shown (35) that exposure
of P388 cells to H202 commits them within a few minutes to subsequent lysis.
Exogenous pyruvate protected P815 mouse mastocytoma cells from H202 in a
similar manner (Table I). All four other a-ketoacids tested substituted for
pyruvate in this protective role, but a fl-ketoacid was ineffective (Table 1).
Acid LDso
MM
Fold shift to right
of dose-response
curve
None 0.08 1
Pyruvate 6.64 83
Oxaloacetate 5.19 65
a-Ketobutyrate 6.32 79
a-Ketocaproate 6.03 75
a-Ketoadipate 6.18 77
,B-Ketoadipate 0.17 2506
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FIGURE 4.
￿
Release of pyruvate into the extracellular medium. Murine P815 cells (a) or
normal diploidhuman Fbroblasts (b) were incubated at 2.5 X 10 6/ml in RPMI 1640 andthen
the medium and cells were prepared for fluorometric assay of pyruvate at the times indicated .
(0) Extracellular pyruvate (juM), (/) cell-associated pyruvate (IM) as determined by measure-
ments of nanomolesof pyruvate per microliter of water in a packed pellet . Means ± SE, n =
3-27 .
Release of Pyruvate by Cells in Culture .
￿
Intracellular pyruvate dropped precip-
itously when cells were transferred to pyruvate-free medium . As the cells replen-
ished their stores, equilibrium between intracellular and extracellular pyruvate
was maintained (Fig . 4a) . The kinetics of pyruvate release showed three phases
(Fig . 4, a and b). A rapid, early release lasted -2 h and averaged 9.4 YM/h/106
human diploid fibroblasts and 19.4 /,M/h/106 P815 cells (cells cultured at 2.5 X
106/ml) . This was followed by a slower phase lasting 4-10 h and averaging 3 .1
kM/h/106 fibroblastsand 6.5 tiM/h/ 106 P815 cells . Finally, a plateau was reached
by 6-12 h, corresponding to reported levels of pyruvate innormal human plasma
and serum (90-120 gM) (36, 37) . Plateau values (micromolar pyruvate in
medium, means ± SE for n experiments, cells cultured at 2 .5 X 106/ml) were
138.0 ± 3 .1 (n = 27) for fibroblasts ; 60.4 ± 4.6 (n = 10) for CAMA-I human
breast adenocarcinoma ; 82.4 ± 5 .2 (n = 3) for SK-BR-2-III human breast
adenocarcinoma ; 149.9 ± 8 .0 (n = 15) for P815 cells ; and 87.9 ± 4.0 (n = 2)
for the L929 mouse connective tissue cell line .
The rate of accumulation of pyruvate in the medium was dependent on the
initial cell density in the range of 10'-106 cells/ml (Fig. 5a). At densities below
10 4 cells/ml, the release of pyruvate over 9 h was below the detection limit of
our assay (Fig. 5b) .
Other a-ketoacids and related metabolic intermediates, with the exception of
lactate, were not released from P815 cells over the 4-h time course studied. GC-
MS analysis of initially pyruvate-free medium, conditioned by P815 cells, showed
that when extracellular pyruvate concentrations had risen close to plateau levels,
there was almost no detectable extracellular succinate, fumarate, citrate, oxal-
oacetate, a-ketoglutarate, or malate (Table II) .
Interrupting the conditioning of the medium with pyruvate by transferring
the cells to fresh pyruvate-free medium resulted in a restart of the process . Cells
interruptedin the steady-state condition (8 h after transfer) immediately resumed
the rapid release characteristic of their first introduction into pyruvate-free
medium (Fig . 6) . Similar results were obtained when cells were transferred
during the earlybuild-up of pyruvate, 2-4 h after transfer to fresh medium (dataIncubation time (h)
￿
Cell density (cells/ml x 10-6 )
FIGURE 5.
￿
Pyruvate release in relation to cell density . P815 mastocytoma cellswere cultured
at various densities in RPMI 1640 andpyruvate in the medium measured at varioustimes. (a)
Pyruvate (juM) in medium vs . time after plating, initial cell density per ml : 10' (/), 3 X 10'
(A), 105 (0), 3 X 105 ([1), 106 (p), 3 X 106 (V), 107 (0) . (b) Pyruvate (1AM) in medium at 9 hvs .
initial plating density . Data are means of duplicates from one representative experiment .
TABLE 11
GC-MS Analysis of Compounds Released into the Culture Medium by P815 Cells
Release after incubation (h)*
￿
Reported in-
* P815 cellswere placed inRPMI (pyruvate-free) at 2.5 X 106 cells/ml . At theindicated
times samples were removed and prepared for GC-MS, or where indicated for
fluorimetric analysis .
Values expressed in micromoles/liter under comparable experimental conditions are
not readily available . Examples are included for HeLa cells (16) and for guinea pig
heart (36) .
4 Meansof duplicates less medium blank .
w Below the limit of detection (0.1-0.5 jumol/liter of medium, depending on the
compound).
not shown) . Cells placed in medium containing 150 tLM pyruvate at time 0
maintained the pyruvate concentration at this initial level (Fig . 6) .
We hypothesized that the slowed rate of accumulation of pyruvate after 2 h
(second phase, Fig . 4) represented a loss of pyruvate to a side-reaction, rather
than a change in the rate of production or release by the cells . This could be
accounted for either by delayed onset of H202 production in the cultures or by
exhaustion of another antioxidant in the medium that protects pyruvate from
reaction with H202 during the first 2 hours . To test this hypothesis we followed
the accumulation of pyruvate in P815 cultures after transfer into pyruvate-free
Compound
1 2 3 4
tracellular
concentra-
tion*
Amol/liter Amol/liter
Pyruvate (fluorimetric) 41 .9¢ 65.3 87.3 106
Pyruvate 35.8 70.6 96.8 109 90
Succinate 0.3 1 .1 1 .8 2.7
Fumarate 0.1 0.5 0.3 0.7
Citrate 0.2 0.7 1 .4 2 .7 280
Oxaloacetate ND° ND ND ND
a-Ketoglutarate ND ND ND ND 380
Malate ND ND ND ND 1,320
Lactate 117 852 1,388 1,454508
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FIGURE 6.
￿
Release of pyruvate after transfer into fresh medium . P815 cells cultured as
described for Fig. 4 were transferred into fresh pyruvate-free medium at the start of the
experiment andagain 8 h later (arrow) . Medium was collected for fluorimetric pyruvate assay
at the times indicated (Q) . A partner set of cells was placed in RPMI 1640 supplemented with
150 uM pyruvate at time 0 (/). Data are means of 2-4 samples from one representative
experiment .
i
Incubation time (h)
Incubation time Ih)
FIGURE 7 .
￿
Enhanced pyruvate accumulation in the presence of catalase. Fibroblasts were
cultured as for Fig . 4 in the presence (/) or absence (O) of 1,000 Sigma U/ml catalase and
medium was collected for fluorometric assay at the times indicated . Means of duplicates from
one representative experiment .
medium with and without 1,000 Sigma U/ml ofadded catalase . The presence of
catalase had little effect on pyruvate accumulation over the first 2 h (Fig . 7), but
thereafter the rate of accumulation of pyruvate in the presence of catalase was
increased 76 ± 28% (n = 6) compared with the noncatalase controls .
Discussion
It is surprising that .mammalian cells in culture divert a substantial portion of
their potential energy supply to the export of pyruvate, and that this has
apparently been documented for only one cell type (26) . Because the export of
pyruvate appears to be specific and widespread among cells ofat least twospecies,
we presume it subserves a physiological function commensurate with its cost to
the cell .
In 1962, Eagle and Piez (38) summarized several reported demonstrations of
a pyruvate requirement for the replication of cells at low population densities .O'DONNELL-TORMEY ET AL .
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To explain the paradox that cells required something they themselves produced,
the authors theorized that at low but not high cell population densities, pyruvate
was lost to the medium faster than cells could make it . This requirement
"disappeared at cell densities sufficiently large to bring the concentration in the
medium and in the cellular pool to metabolically effective levels before the cell
died of the specific deficiency" (38) . However, the postulated release of pyruvate
was never demonstrated . This may have been due in part to the technical
difficulty of measuring pyruvate by NADH-linked enzymatic assays in the pres-
ence of interfering substances, including LDH, in cell-conditioned culture media.
We have carefully optimized an enzymatic assay for pyruvate in cell culture
medium, and validated it by reference to GGMS analysis . In agreement with
Eagle's and Piez's hypothesis, we have found that (a) cells rapidly releasepyruvate
into the extracellular medium, (b) the rate of accumulation is dependent on cell
density, and (c) the concentration of intracellular pyruvate corresponds closely
to that of extracellular pyruvate at all times . At low plating density, the increased
time required by cells to condition the extracellular medium to homeostatic
levels of pyruvate prolonged the depletion of intracellular pyruvate, thus expos-
ing cells to the deleterious effects of oxidants, as well as to other metabolic
constraints, for many hours . Further, we have used the GGMS technique to
analyze cell-conditioned medium simultaneously for eight glycolytic and Krebs
cycle intermediates . Only pyruvate and lactate were released from P815 cells,
even though the intracellular concentrations of some of the other intermediates
were expected to exceed that of pyruvate . Thus, neither cell lysis nornonspecific
permeability of the plasma membrane could account for the accumulation of
pyruvate in cell-conditioned medium . Pyruvate release appears to be a specific
secretory phenomenon .
All the mouse and human cells tested, whether normal or malignant, were
able to bring both intracellular and extracellular pyruvate to a homeostatic level
(60-150,4M), corresponding approximately to that in human plasma and serum
(36, 37) as long as they were plated at ;10' cells/ml . When we replaced
conditioned medium with pyruvate-free medium, extracellular accumulation of
pyruvate commenced by the first time point studied and paralleled intracellular
levels until both had reached homeostatic levels . When conditioned medium was
replaced with fresh medium supplemented with 150 uM pyruvate, no accumu-
lation of pyruvate was induced . When we varied the ratio of cell number to
volume of the medium, the amount of pyruvate secreted per cell was not fixed,
but varied in such a way as to bring the extracellular concentration of pyruvate
to the plateau level found intracellularly for each cell type . We have no under-
standing of what determines the homeostatic set point for intracellu-
lar/extracellular pyruvate . The plateau was not due to exhaustion of glucose in
the medium (data not shown) . Extracellular pyruvate could not arise from
secreted lactate via the action of LDH and NAD released from dying cells,
because the equilibrium constant of the reaction is 2 x 10-' 2 M in favor of lactate
(39) .
Other carboxylated metabolic intermediates (succinate, fumarate, citrate, ox-
aloacetate, a-ketoglutarate, malate) were not exported from P815 cells in signif-
icant amounts, except lactate . The flux of lactate was even greater than that of51 0
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pyruvate . The operation of a specific transmembrane carrier system for these
two compounds would be consistent with these findings . Because of the close
similarity of pyruvate and lactate, a carrier system might mediate the movement
of both . A pyruvate carrier has been demonstrated in mitochondria (40-45),
erythrocytes (40), and intestinal epithelial cells (46) . The lactate carrier in
hepatocyte membranes binds pyruvate, and this inhibits lactate transport (47-
49) . The probable role of the lactate carrier as a pyruvate transporter has
apparently not been considered .
Antioxidant functions have been ascribed to many molecules, but few ofthem
are known to appear extracellularly in the absence of cell lysis . Plasma urate (0.3
mM) is prominent among the components of extracellular fluid that react
nonspecifically with hydroxyl radical (50) . Ceruloplasmin serves as a superoxide
dismutase (51) in plasma . Some cells may secrete a novel superoxide dismutase
(52) . Plasma ascorbate (27-50 yM) (53) and tocopherol (24 AM) (54) may
scavengeH202 . Plasma glutathione is reported to be 21 AM in the reduced form
(55) that is reactive with H202 . Thus, pyruvate plasma or serum levels (90-120
AM [36, 37]) may be the major scavenger of H202 in extracellular fluid. The
observation that exogenous catalase enhanced the rate of accumulation of se-
creted pyruvate strongly suggests that pyruvate actually functions as an extracel-
lular scavenger ofH202 arising in cell culture .
The ability of exogenous pyruvate to protect bacteria from endogenous or
exogenous oxidants has been recognized since 1934 (56-64). However, the
ability ofexogenous pyruvate to protect mammalian cells from H202 was appar-
ently first reported only in 1985 (65), while this study was in progress . Indeed,
exogenous pyruvate has probably acted as an unrecognized antioxidant in many
studies ofthe toxicity ofH202 to mammalian cells . Moreover, the use ofpyruvate-
free medium in many otherstudies has no doubt imposed metabolic stress . These
points should now be considered in the design, interpretation, and comparison
of studies of oxidant injury . More generally, cell culture techniques should now
take the role of pyruvate into account on a rational basis, rather than on the
empiric basis formerly used . This may be especially important in cloning and in
establishing cultures ex vivo . Finally, because pyruvate is presumably nontoxic,
and because it is freely diffusible from the intravascular to the extravascular,
intercellular, and intracellular spaces, consideration should be given to testing
whether administration of pyruvate might afford a beneficial antioxidant effect
in certain pathophysiologic states .
There is an obvious advantage to cells in scavenging exogenous H202 before
it reaches the cell . It is likely that intracellular a-ketoacids also scavenge intra-
cellular H202, but this remains to be demonstrated . Future studies will analyze
whether differences in the capacity to synthesize and secrete pyruvate during
oxidant stress may underlie some of the hitherto unexplained variation among
cell types in susceptibility to oxidant injury .
Summary
Cells in culture are exposed to marked oxidative stress, H202 being one of the
predominant agents . Pyruvate and other a-ketoacids reacted rapidly, stoichio-
metrically, and nonenzymatically with H202 , and they protected cells from itscytolytic effects . All five human and murine cell types studied, both malignant
and nonmalignant, released pyruvate at an initial rate of 35-60 /M/h/2.5 X 106
cells when placed in 1 ml pyruvate-free medium . After 6-12 h a plateau of 60-
150 AM pyruvate was attained, corresponding to concentrations reported for
normal human serum and plasma . The rate of pyruvate accumulation was almost
doubled in the presence ofexogenous catalase, suggesting that released pyruvate
functions as an antioxidant . The rate of pyruvate accumulation was dependent
on cell number . Succinate, fumarate, citrate, oxaloacetate, a-ketoglutarate, and
malate were not secreted in significant amounts from P815 cells ; export was
specific for pyruvate and lactate among the metabolites tested . Extracellular
pyruvate was in equilibrium with intracellular stores . Thus, cells conditioned the
extracellular medium with pyruvate at the expense of intracellular pyruvate,
until homeostatic levels were attained in both compartments . We propose that
cells plated at low density in the absence ofexogenous pyruvate fail to thrive for
two reasons : prolonged depletion of intracellular pyruvate and prolonged vul-
nerability to oxidant stress .
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